Clinical studies with beta 2 adrenoceptor agonists in heart failure.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000420:Albuterol / Q000494:pharmacology; D000631:Aminopyridines / Q000494:pharmacology; D000676:Amrinone; D002316:Cardiotonic Agents / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology
D000318:Adrenergic beta-Agonists; D000631:Aminopyridines; D002316:Cardiotonic Agents; D004983:Ethanolamines; D000676:Amrinone; C009118:pirbuterol; D000420:Albuterol